<Disease><Name>5-OXOPROLINASE DEFICIENCY (OPLAHD)</Name><Synonym>5-OXOPROLINURIA</Synonym><OMIM><Number>260005</Number><URL>http://omim.org/entry/260005</URL></OMIM><Orphanet><Number>33572</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=33572</URL></Orphanet><Protein><Number>5-oxoprolinase</Number><URL>http://www.uniprot.org/uniprot/O14841</URL></Protein><ExPASy><Number>3.5.2.9</Number><URL>http://enzyme.expasy.org/EC/3.5.2.9</URL></ExPASy><Gene>8q24.3</Gene><ICD>E72.8</ICD><Summary>rare ;autosomal recessive;mutation in OPLAH gene;other causes of 5-oxoproline excretion: infantile formula malnutrition, prematurity, acetaminophen and other drugs (in adults) severe burns unresolved [Ruijter GJG et al. 2006]</Summary><Symptoms><symtomp><id>2347</id><symptom>anemia</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2321</id><symptom>cleft palate</symptom><category>HEAD</category></symtomp><symtomp><id>3975</id><symptom>colitis or enterocolitis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2065</id><symptom>metabolic acidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1717</id><symptom>no clinical symptoms (probably) / no clinical  significance</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>4105</id><symptom>no consistent clinical picture</symptom><category /></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2089</id><symptom>Organic acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1975</id><symptom>pain, abdominal / pain abdominal</symptom><category>BODY | GENERAL TOPICS</category></symtomp><symtomp><id>3988</id><symptom>renal colic</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1872</id><symptom>respiratory distress</symptom><category>LUNG OR RESPIRATORY SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2236</id><symptom>urolithiasis, nephrolithiasis, kidney stones</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>746</id><name>5-Oxoprolinase</name><specimen>leucocytes</specimen><value>decreased</value><min>36.00</min><max>104.00</max><unit>pkat/g protein</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>747</id><name>5-Oxoprolinase</name><specimen>fibroblasts</specimen><value>decreased</value><min>49.00</min><max>105.00</max><unit>pkat/g protein</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>72</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>42.00</min><max>115.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>560</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>54.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>563</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>all</age><method /><comment /></metabolite><metabolite><id>1168</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>77.00</min><max>133.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1284</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>blood</specimen><value>increased</value><min>14.00</min><max>62.54</max><unit>&#181;mol/ml</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1285</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>serum</specimen><value>increased</value><min>23.80</min><max>106.32</max><unit>&#181;mol/ml</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1977</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>10.20</min><max>32.60</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>394</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>plasma</specimen><value>increased</value><min>13.00</min><max>161.00</max><unit>&#181;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>559</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>44.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite></Metabolites><Literatures><literature><id>4531</id><title>Unravelling 5-oxoprolinuria (pyroglutamic aciduria) due to bi-allelic OPLAH mutations: 20 new mutations in 14 families</title><author>Sass JO,</author><journal>Mol Genet Metab</journal><year>2016</year><book /><volume>119</volume><number>1</number><pages>44-49</pages><co_aut>et al.</co_aut></literature><literature><id>3288</id><title>Transient 5-oxoprolinuria: unusually high anion gap acidosis in an infant</title><author>Hulley SL,</author><journal>Eur J Pediatr</journal><year>2015</year><book /><volume>174</volume><number>12</number><pages>1685-1688</pages><co_aut>et al.</co_aut></literature><literature><id>3289</id><title>New insights into the genetics of 5-oxoprolinase deficiency and further evidence that it is a benign biochemical condition</title><author>Calpena E,</author><journal>Eur J Pediatr</journal><year>2015</year><book /><volume>174</volume><number>3</number><pages>407-411</pages><co_aut>et al.</co_aut></literature><literature><id>3286</id><title>A rare cause of high anion gap metabolic acidosis</title><author>Milosevic S,</author><journal>Intern Med J</journal><year>2013</year><book /><volume>43</volume><number>1</number><pages>100-101</pages><co_aut>Tran K, OBrien B</co_aut></literature><literature><id>3287</id><title>What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamo</title><author>Liss DB,</author><journal>Clin Toxicol (Phila)</journal><year>2013</year><book /><volume>51</volume><number>9</number><pages>817-827</pages><co_aut>et al.</co_aut></literature><literature><id>3067</id><title>5-Oxoprolinase deficiency: report of the first human OPLAH mutation.</title><author>Almaghlouth IA,</author><journal>Clin Genet</journal><year>2012</year><book /><volume>82</volume><number>2</number><pages>193-196</pages><co_aut>et al.</co_aut></literature><literature><id>2848</id><title>Inborn errors in the metabolism of glutathione</title><author>Ristoff E,</author><journal>Orphanet J Rare Dis</journal><year>2007</year><book /><volume>2</volume><number>16</number><pages /><co_aut>Larsson A</co_aut></literature><literature><id>2617</id><title>Persistent 5-oxoprolinuria with normal glutathione synthase and 5-oxoprolinase activities</title><author>Ruijter GJ</author><journal>J Inher Met Dis</journal><year>2006</year><book /><volume>29</volume><number>0</number><pages>587</pages><co_aut>et al.</co_aut></literature><literature><id>2618</id><title>Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital</title><author>Humphreys BD</author><journal>Am J Kidney Dis</journal><year>2005</year><book /><volume>46</volume><number>0</number><pages>143-146</pages><co_aut>et al.</co_aut></literature><literature><id>1543</id><title>A newborn infant with generalized glutathione synthetase deficiency</title><author>Yapicioglu H</author><journal>Turk J Pediatr</journal><year>2004</year><book /><volume>46</volume><number>1</number><pages>72-75</pages><co_aut>et al.</co_aut></literature><literature><id>1375</id><title>5-Oxoprolinuria: a cause of neonatal metabolic acidosis</title><author>Mitanchez D</author><journal>Acta Paediatr</journal><year>2001</year><book /><volume>90</volume><number>7</number><pages>827-828</pages><co_aut>et al.</co_aut></literature><literature><id>1376</id><title>5-Oxoprolinuria in patients with and without defects in the gamma-glutamyl cycle</title><author>Mayatepek E</author><journal>Eur J Pediatr</journal><year>1999</year><book /><volume>158</volume><number>3</number><pages>221-225</pages><co_aut /></literature><literature><id>1544</id><title>Clinical, biochemical, and molecular characterization of patients with glutathione synthetase deficiency</title><author>Al-Jishi E</author><journal>Clin Genet</journal><year>1999</year><book /><volume>55</volume><number>6</number><pages>444-449</pages><co_aut>et al.</co_aut></literature><literature><id>1545</id><title>Patients with genetic defects in the gamma-glutamyl cycle</title><author>Ristoff E</author><journal>Chem Biol Interact</journal><year>1998</year><book /><volume>111</volume><number>0</number><pages>113-121</pages><co_aut>Larsson A</co_aut></literature><literature><id>33</id><title>5-Oxoprolinase deficiency associated with severe psychomotor developmental delay, failure to thrive, microcephaly and microcytic</title><author>Mayatepek E</author><journal>J Inher Metab Dis</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>83-84</pages><co_aut>Hoffmann GF, Larsson A, Becker K, Bremer HJ</co_aut></literature><literature><id>108</id><title>Glutathione synthetase deficiency and other disorders of the gamma-glutamyl cycle</title><author>Meister A</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>0</number><pages>1461-1477</pages><co_aut>Larsson A</co_aut></literature></Literatures></Disease>